Categories: AppsHealthcareNews

Health Catalyst Announces Strategic Partnership with Microsoft to Accelerate AI Adoption and Transformation for Care Delivery Organizations

Health Catalyst’s Improvement Expertise Built on Microsoft Azure and Azure AI Foundry to Drive Reliable Insight and Sustained Outcomes for Care Providers

SALT LAKE CITY, April 29, 2025 /PRNewswire/ — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced a strategic partnership with Microsoft to help healthcare organizations accelerate operational, clinical, and financial performance through AI-driven innovation.

The collaboration further builds on Health Catalyst’s expertise with Microsoft Azure and Azure AI Foundry capabilities, equipping healthcare organizations with advanced AI solutions to accelerate time to value, enhance care delivery, and drive measurable, long-term improvement. 

Healthcare.AI™: Enhanced Analytics and Health Catalyst Ignite™ are transactable on the Azure Marketplace today. Additional solutions will become available. This will enable healthcare organizations to solve problems across data and analytics, cybersecurity, financial, and operational improvement as part of their existing relationship with Microsoft.

“To achieve their goals for 2025 and beyond, healthcare organizations recognize that they need to move beyond data and analytics to reliable action and sustained outcomes,” said Dave Ross, Chief Technology and Product Officer at Health Catalyst. “By combining machine intelligence with our unique improvement services expertise, our partnership with Microsoft will massively extend our reach and bring sustainable performance improvement to clients of all size and scale.”

“Realizing transformative value from AI requires more than just powerful technology — it demands deep healthcare expertise,” said Dan Samarov, PHD, Chief AI Officer at Health Catalyst. “This partnership accelerates AI-driven outcomes by uniting best-in-class AI offerings with our unique industry-specific knowledge and applications.”

“Our partnership truly showcases the incredible synergy between transformative technology and deep industry expertise,” said Patty Carrolo, CVP of US Health and Life Sciences at Microsoft. “By bringing Health Catalyst’s Ignite and Healthcare.AI solutions to the Azure Marketplace, we are enabling healthcare organizations to accelerate AI adoption, optimize decision-making, and achieve meaningful, scalable outcomes with ease. Together, we are elevating data-driven healthcare innovation.”

About Health Catalyst
Health Catalyst (Nasdaq: HCAT) is a leading provider of data and analytics technology and services that ignite smarter healthcare, lighting the path to measurable clinical, financial, and operational improvement. More than 1,000 organizations worldwide rely on Health Catalyst’s offerings, including our cloud-based technology ecosystem, Health Catalyst Ignite™, AI-enabled data and analytics solutions, and expert services to drive meaningful outcomes across hundreds of millions of patient records. Powered by high-value data, standardized measures and registries, and deep healthcare domain expertise, Ignite helps organizations transform complex information into actionable insights. Backed by a multi-decade mission and a proven track record of delivering billions of dollars in measurable results, Health Catalyst continues to serve as the catalyst for massive, data-informed healthcare improvement and innovation.

Media Contact:
Kathryn Mykleseth
Director of Public Relations and Communications
media@healthcatalyst.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-catalyst-announces-strategic-partnership-with-microsoft-to-accelerate-ai-adoption-and-transformation-for-care-delivery-organizations-302440565.html

SOURCE Health Catalyst

Staff

Recent Posts

CannaPharmaRX Provides Corporate Update and Outlines Growth Strategy for 2026

CALGARY, AB / ACCESS Newswire / January 12, 2026 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an…

1 hour ago

TempraMed Closes C$2.5 Million Fully Subscribed Private Placement

Vancouver, British Columbia--(Newsfile Corp. - January 12, 2026) - TempraMed Technologies Ltd. (CSE: VIVI) (FSE:…

4 hours ago

TruuCONNECT NJ Statewide Digital Hub Empowers Users to Find Verified, Local Community Resources and Support – Anonymously and in Real Time

MOUNT LAUREL, N.J., Jan. 12, 2026 /PRNewswire/ -- Born out of a partnership between the…

4 hours ago

Nuvo Unveils Large-Scale AI-Ready Pregnancy Dataset Built on Real-World Maternal and Fetal Physiology

Unique longitudinal dataset combining native fetal and maternal ECG with phonocardiography supports deeper insights into…

4 hours ago

Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer’s Disease Research

FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision…

4 hours ago

RxAnte Announces Strategic Growth Investment from Primus Capital

PORTLAND, Maine, Jan. 12, 2026 /PRNewswire/ -- RxAnte, the leading provider of analytics, software, and…

4 hours ago